STARTENGINE CROWDFUNDING, INC.

2023 Q4 Form 10-Q Financial Statement

#000155837023019068 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.66M $15.83M
YoY Change -18.14% 7.96%
Cash & Equivalents $13.00M $15.80M
Short-Term Investments $1.860K $1.860K
Other Short-Term Assets $720.8K $2.165M
YoY Change -63.11% 13.92%
Inventory
Prepaid Expenses
Receivables $193.7K $744.9K
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.57M $18.74M
YoY Change -25.09% 5.52%
LONG-TERM ASSETS
Property, Plant & Equipment $119.7K $119.1K
YoY Change 9.7% 9.27%
Goodwill
YoY Change
Intangibles $21.89M $23.49M
YoY Change 109360.96% 117361.35%
Long-Term Investments $17.76M $14.79M
YoY Change 34.69% 13.31%
Other Assets $42.14K $67.11K
YoY Change -36.73% -3.32%
Total Long-Term Assets $40.02M $38.47M
YoY Change 199.1% 190.26%
TOTAL ASSETS
Total Short-Term Assets $13.57M $18.74M
Total Long-Term Assets $40.02M $38.47M
Total Assets $53.59M $57.21M
YoY Change 70.15% 84.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $278.7K $388.1K
YoY Change -2.0% -31.02%
Accrued Expenses $4.457M $3.603M
YoY Change 153.09% 111.08%
Deferred Revenue $3.520M $3.596M
YoY Change 29.64% 50.35%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.256M $7.587M
YoY Change 73.41% 62.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.256M $7.587M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.256M $7.587M
YoY Change 73.41% 62.77%
SHAREHOLDERS EQUITY
Retained Earnings -$44.64M -$36.00M
YoY Change 66.15% 26.25%
Common Stock $343.00 $342.00
YoY Change 3.31% 3.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.35M $49.64M
YoY Change
Total Liabilities & Shareholders Equity $53.59M $57.21M
YoY Change 70.15% 84.47%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001661779
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34655810
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33301662
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
false
none Maximum Term Of Contract With Customers
MaximumTermOfContractWithCustomers
P1Y
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56415
dei Entity Registrant Name
EntityRegistrantName
StartEngine Crowdfunding, Inc.
dei Entity Address Address Line1
EntityAddressAddressLine1
4100 West Alameda Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Burbank
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91505
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
317-2200
dei Security12g Title
Security12gTitle
Common Stock, $0.00001 par value
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34655810
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15829806
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15460469
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4161
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1856
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1856
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
744878
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
702257
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2164690
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1953756
CY2023Q3 us-gaap Assets Current
AssetsCurrent
18741230
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18118338
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
119095
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109141
CY2023Q3 none Investment In Warrants Noncurrent
InvestmentInWarrantsNoncurrent
1497442
CY2022Q4 none Investment In Warrants Noncurrent
InvestmentInWarrantsNoncurrent
1496701
CY2023Q3 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
8654081
CY2022Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
6479340
CY2023Q3 none Investment In Collectibles Noncurrent
InvestmentInCollectiblesNoncurrent
2504822
CY2022Q4 none Investment In Collectibles Noncurrent
InvestmentInCollectiblesNoncurrent
3072227
CY2023Q3 us-gaap Real Estate Investments
RealEstateInvestments
2136628
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
2136628
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23492269
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67107
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
66603
CY2023Q3 us-gaap Assets
Assets
57212674
CY2022Q4 us-gaap Assets
Assets
31498978
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
388095
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
284371
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3602655
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1760920
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3595858
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2715422
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7586608
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4760713
CY2023Q3 us-gaap Liabilities
Liabilities
7586608
CY2022Q4 us-gaap Liabilities
Liabilities
4760713
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34655810
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33301662
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
342
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
332
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
77658260
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45639151
CY2023Q3 us-gaap Minority Interest
MinorityInterest
-13251
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-13251
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35996342
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26865024
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49626066
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26738265
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57212674
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31498978
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5701917
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5229159
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15660161
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19578222
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1715915
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1753004
us-gaap Cost Of Revenue
CostOfRevenue
4623131
us-gaap Cost Of Revenue
CostOfRevenue
5451888
CY2023Q3 us-gaap Gross Profit
GrossProfit
3986002
CY2022Q3 us-gaap Gross Profit
GrossProfit
3476155
us-gaap Gross Profit
GrossProfit
11037030
us-gaap Gross Profit
GrossProfit
14126334
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2766779
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2639351
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6692247
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9936537
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3470654
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2572402
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9317490
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9901596
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1701921
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1398330
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4159141
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4010775
CY2022Q3 none Impairment In Value Of Shares Received For Fees
ImpairmentInValueOfSharesReceivedForFees
21863
none Impairment In Value Of Shares Received For Fees
ImpairmentInValueOfSharesReceivedForFees
21863
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7939354
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6631946
us-gaap Operating Expenses
OperatingExpenses
20168878
us-gaap Operating Expenses
OperatingExpenses
23870771
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3953352
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3155791
us-gaap Operating Income Loss
OperatingIncomeLoss
-9131848
us-gaap Operating Income Loss
OperatingIncomeLoss
-9744437
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20286
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85086
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65462
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
216204
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20286
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
85086
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
65462
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
216204
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3933066
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3070705
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9066386
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9528233
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39466
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64932
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62345
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3972532
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-3074866
us-gaap Profit Loss
ProfitLoss
-9131318
us-gaap Profit Loss
ProfitLoss
-9590578
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9124
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3972532
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3074866
us-gaap Net Income Loss
NetIncomeLoss
-9131318
us-gaap Net Income Loss
NetIncomeLoss
-9581454
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34614795
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34614795
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33086652
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33086652
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33946962
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33946962
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33086652
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33086652
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27914633
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18521
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1979475
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2148468
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27764161
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3103107
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3456142
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2120552
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4358120
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25173558
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2488107
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
504781
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2271732
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3074866
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26353750
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26738265
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1124509
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20972
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
897634
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
770651
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2059917
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25950812
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1900455
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
375
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1927283
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
24000000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
802248
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3098869
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49877805
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2617698
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50875
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2080565
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1028345
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3972532
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49626066
us-gaap Profit Loss
ProfitLoss
-9131318
us-gaap Profit Loss
ProfitLoss
-9590578
us-gaap Depreciation
Depreciation
9817
us-gaap Depreciation
Depreciation
9817
us-gaap Adjustment For Amortization
AdjustmentForAmortization
648767
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
98864
none Fair Value Of Warrants Received For Fees
FairValueOfWarrantsReceivedForFees
741
none Fair Value Of Warrants Received For Fees
FairValueOfWarrantsReceivedForFees
367385
none Fair Value Of Investments Other Received For Fees
FairValueOfInvestmentsOtherReceivedForFees
2174741
none Fair Value Of Investments Other Received For Fees
FairValueOfInvestmentsOtherReceivedForFees
1848516
none Impairment In Value Of Shares Received For Fees
ImpairmentInValueOfSharesReceivedForFees
21863
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
52845
us-gaap Share Based Compensation
ShareBasedCompensation
4905482
us-gaap Share Based Compensation
ShareBasedCompensation
6371759
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42621
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-182610
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
211438
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1563495
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
103724
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11225
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1841735
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-900672
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
880436
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1720163
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3170898
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6242976
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
74353
none Payments To Acquire Collectibles
PaymentsToAcquireCollectibles
1691880
none Proceeds From Sale Of Investment In Collectibles
ProceedsFromSaleOfInvestmentInCollectibles
567405
none Purchase Asset Intangible
PurchaseAssetIntangible
-121037
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19771
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61269
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
426597
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1827502
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5642663
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5223383
none Payments For Subscription Receivable
PaymentsForSubscriptionReceivable
-367832
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2601245
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3960923
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
72220
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18521
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
9124
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3113638
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1657937
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
369337
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6412541
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15460469
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21000367
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15829806
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14587826
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64932
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
62344
none Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsideration
24000000
none Subscription Receivable As Part Of Common Stock
SubscriptionReceivableAsPartOfCommonStock
367832
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1 – NATURE OF OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">StartEngine Crowdfunding, Inc. was formed on March 19, 2014 (“Inception”) in the State of Delaware. The Company was originally incorporated as StartEngine Crowdsourcing, Inc. and changed to the current name on May 8, 2014. The condensed consolidated financial statements of StartEngine Crowdfunding, Inc. (the “Company” are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Company’s headquarters are located in Burbank, California.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company aims to revolutionize the startup financing model by helping both accredited and non-accredited investors invest in private companies on a public platform. StartEngine Crowdfunding Inc. has wholly-owned subsidiaries, StartEngine Capital LLC, StartEngine Secure LLC, StartEngine Assets LLC and StartEngine Primary LLC. StartEngine Capital LLC is a funding portal registered with the US Securities and Exchange Commission (SEC) and a member of the Financial Industry Regulatory Authority (FINRA), StartEngine Secure LLC is a transfer agent registered with the SEC. StartEngine Assets LLC was formed in 2020 to buy, hold and manage assets in various asset classes such as real estate, automobiles, luxury goods and royalty-producing intangible assets. StartEngine Primary LLC was formed in October 2017 and received approval to operate as a registered broker-dealer in July 2019. On April 16, 2020, StartEngine Primary LLC received approval to operate as an alternative trading system. StartEngine Adviser LLC is a wholly owned subsidiary of StartEngine Crowdfunding. StartEngine Adviser LLC will file as an exempt reporting adviser that will advise StartEngine Private LLC and it’s related series.  StartEngine Adviser LLC is not registered with the Securities and Exchange Commission as an investment adviser. StartEngine Private Manager LLC is a wholly owned subsidiary of StartEngine Crowdfunding - it is the manager of StartEngine Private and the Series’. The Company’s mission is to empower thousands of companies to raise capital and create significant amounts of jobs over the coming years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Management Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s revenue producing activities commenced in 2015 with the approved start of Title IV of the JOBS Act, which created new rules for Regulation A, and increased since then with the start of Regulation Crowdfunding under Title III of the JOBS Act. Because this is a relatively new industry, there is a level of uncertainty about how fast the volume of activity will increase and how future regulatory requirements may change the landscape. Because there is a level of uncertainty and because we are still in the early stages of these new regulations, the Company is expected to incur losses until such time that the volume of Regulation A, Regulation D and Regulation Crowdfunding campaigns and the investments in those campaigns is sufficient for revenues derived from those campaigns to cover its costs. These factors could indicate substantial doubt about the Company’s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has cash and cash equivalents of approximately $15.8 million, which its management believes will cover losses for the foreseeable future. The Company’s management believes that any substantial doubt about the Company’s ability to continue as a going concern has been alleviated.</p>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15800000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amount of expenses during the reporting periods. Significant estimates include the value of marketable securities, the value of stock and warrants received as compensation and collectability of accounts receivable. Actual results could materially differ from these estimates. It is reasonably possible that changes in estimates will occur in the near term.</p>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1512097
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
357709
none Provision For Doubtful Accounts Other
ProvisionForDoubtfulAccountsOther
162535
none Provision For Doubtful Accounts Other
ProvisionForDoubtfulAccountsOther
98864
CY2023Q3 none Accounts Receivable Over Ninety Days
AccountsReceivableOverNinetyDays
458197
none Cost Of Stock Received As Payment For Fees
CostOfStockReceivedAsPaymentForFees
2175170
none Cost Of Stock Received As Payment For Fees
CostOfStockReceivedAsPaymentForFees
1891748
none Shares Received As Payment For Fees Impairment Charge
SharesReceivedAsPaymentForFeesImpairmentCharge
0
none Shares Received As Payment For Fees Impairment Charge
SharesReceivedAsPaymentForFeesImpairmentCharge
21863
CY2023Q3 none Wine Noncurrent
WineNoncurrent
316888
CY2022Q4 none Wine Noncurrent
WineNoncurrent
476115
CY2023Q3 none Trading Cards Noncurrent
TradingCardsNoncurrent
486657
CY2022Q4 none Trading Cards Noncurrent
TradingCardsNoncurrent
486657
CY2023Q3 none Artwork Noncurrent
ArtworkNoncurrent
1182942
CY2022Q4 none Artwork Noncurrent
ArtworkNoncurrent
1287378
CY2023Q3 none Comic Books Noncurrent
ComicBooksNoncurrent
464477
CY2022Q4 none Comic Books Noncurrent
ComicBooksNoncurrent
704477
CY2023Q3 none Non Fungible Token Noncurrent
NonFungibleTokenNoncurrent
730
CY2022Q4 none Non Fungible Token Noncurrent
NonFungibleTokenNoncurrent
64472
CY2023Q3 none Watches Noncurrent
WatchesNoncurrent
53128
CY2022Q4 none Watches Noncurrent
WatchesNoncurrent
53128
CY2023Q3 none Investment In Collectibles Noncurrent
InvestmentInCollectiblesNoncurrent
2504822
CY2022Q4 none Investment In Collectibles Noncurrent
InvestmentInCollectiblesNoncurrent
3072227
CY2023Q3 none Cryptocurrencies Current
CryptocurrenciesCurrent
24969
CY2022Q4 none Cryptocurrencies Current
CryptocurrenciesCurrent
16604
CY2023Q3 none Number Of Bitcoins Held
NumberOfBitcoinsHeld
1
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
38773
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
none Decrease In Non Fungible Token Price
DecreaseInNonFungibleTokenPrice
47138
none Increase In Bitcoin Price
IncreaseInBitcoinPrice
8365
CY2023Q3 none Additions And Property Improvements Capitalized
AdditionsAndPropertyImprovementsCapitalized
5000
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
2136628
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
504781
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3960923
none Membership Fee Per Year
MembershipFeePerYear
275
none Percentage Of Bonus Shares That Members Are Entitled
PercentageOfBonusSharesThatMembersAreEntitled
0.10
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2715422
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5701917
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5229159
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15660161
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19578222
CY2023Q3 none Research And Development Expense Other
ResearchAndDevelopmentExpenseOther
1701921
none Research And Development Expense Other
ResearchAndDevelopmentExpenseOther
4159141
CY2022Q3 none Research And Development Expense Other
ResearchAndDevelopmentExpenseOther
1398330
none Research And Development Expense Other
ResearchAndDevelopmentExpenseOther
4010775
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1856
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1856
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">September 30, </p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,301,662</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Shares sold</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 645,300</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total common stock equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,948,985</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">September 30, </p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding - basic</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30,652,394</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Preferred shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,910,222</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,339,585</p></td></tr><tr><td style="vertical-align:bottom;width:84.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average shares outstanding - diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 56,902,201</p></td></tr></table>
CY2022 none Weighted Average Shares Outstanding Beginning Balance
WeightedAverageSharesOutstandingBeginningBalance
33301662
none Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
645300
none Total Common Stock Equivalents
TotalCommonStockEquivalents
33948985
none Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
30652394
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
20910222
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5339585
none Weighted Average Shares Outstanding Diluted
WeightedAverageSharesOutstandingDiluted
56902201
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
160573
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
140801
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41478
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31660
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
119095
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109141
us-gaap Depreciation
Depreciation
9817
us-gaap Depreciation
Depreciation
9817
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25950000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 none Common Stock Shares Authorized After Split
CommonStockSharesAuthorizedAfterSplit
75000000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
260818
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
318537
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3960923
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4905482
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6371760
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4905482
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6371760
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
22233009
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M4D

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-23-019068-index-headers.html Edgar Link pending
0001558370-23-019068-index.html Edgar Link pending
0001558370-23-019068.txt Edgar Link pending
0001558370-23-019068-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20230930.xsd Edgar Link pending
tmb-20230930x10q.htm Edgar Link pending
tmb-20230930xex31d1.htm Edgar Link pending
tmb-20230930xex32d1.htm Edgar Link pending
tmb-20230930_cal.xml Edgar Link unprocessable
tmb-20230930_lab.xml Edgar Link unprocessable
tmb-20230930_pre.xml Edgar Link unprocessable
tmb-20230930_def.xml Edgar Link unprocessable
tmb-20230930x10q_htm.xml Edgar Link completed